Edition:
India

People: Concert Pharmaceuticals Inc (CNCE.OQ)

CNCE.OQ on NASDAQ Stock Exchange Global Market

10.80USD
20 Sep 2019
Change (% chg)

$-0.08 (-0.74%)
Prev Close
$10.88
Open
$10.88
Day's High
$10.91
Day's Low
$10.48
Volume
140,421
Avg. Vol
52,065
52-wk High
$17.80
52-wk Low
$9.23

van Heek, Christine 

Ms. Christine van Heek is an Independent Director of Concert Pharmaceuticals Inc. Ms. van Heek has served as a member of our Board of Directors since April 2016. Ms. van Heek has served as an adviser and consultant to several companies in the bio-pharmaceutical industry. From 1991 to 2003, Ms. van Heek served in various roles at Genzyme, Inc., a biotechnology company, including positions as Corporate Officer and President, Therapeutics Division; General Manager, Renal Division; and Vice President, Global Marketing. In addition, she has held various sales and marketing positions at Genentech, Inc. and Caremark/HHCA. During the last five years, Ms. van Heek also served as a member of the board of directors of Affymax, Inc., a biopharmaceutical company. Ms. van Heek holds an M.B.A. from Lindenwood University in St. Louis and a B.S.N. from the University of Iowa. We believe that Ms. van Heek's industry experience, including her extensive experience in strategic roles of a publicly traded biotechnology company, make her a key contributor to our Board of Directors.

Basic Compensation

Total Annual Compensation, USD 47,500
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 133,748
Fiscal Year Total, USD 181,248

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Aldrich

205,613

Roger Tung

4,607,850

Marc Becker

2,450,530

Nancy Stuart

1,908,030

James Cassella

1,960,240

Thomas Auchincloss

205,613
As Of  31 Dec 2018